MedX Health Corp.

About MedX Health Corp.

MedX Health is a company focused on redefining dermatology through accessibility, imaging, and interoperability. Their mission is to save lives by delivering detailed imagery of lesions to dermatologists and consultants efficiently via telehealth solutions.

Products & Services

Teledermatology (DermSecure Platform):A telehealth platform developed with dermatologists for efficient and secure delivery of dermatological assessments. It is the only fully FDA-approved Class IIa platform, providing highly accurate images and a 5-sectional analysis of moles within minutes.

MedX Laser Therapy:A trusted, proven, and versatile laser therapy solution for dermatological applications.

DermSecure

MedX Laser Therapy

Specialties

Teledermatology Dermatological Imaging Telehealth Laser Therapy Interoperability with Electronic Health Records (HL7 FHIR protocols) Skin chromophore mapping Non-invasive skin cancer detection Photobiomodulation (PBM) laser therapy Longitudinal skin health analysis

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Convertible Loan Notes T: - FT: Convertible Loan Notes	A: 2700000 MR: - FA: 2,700,000 FAN: 2700000	D: 2026-04-15 FD: 2026-04-15	-
2	RT: Convertible Debt T: - FT: Convertible Debt	A: 2700000 MR: - FA: $2,700,000 FAN: 2700000	D: 2026-03-16 FD: 2026-03-16	-
3	RT: Convertible Debt T: - FT: Convertible Debt	A: 2700000 MR: - FA: 2,700,000 FAN: 2700000	D: 2026-02-27 FD: 2026-02-27	-
4	RT: Non-Brokered Private Placement of Series IV Convertible Loan Notes T: - FT: Non-Brokered Private Placement of Series IV Convertible Loan Notes	A: 5000000 MR: - FA: up to $5 million FAN: 5000000	D: 2026-02-02 FD: 2026-02-02	-
5	RT: Non-brokered Private Placement T: - FT: Non-brokered Private Placement	A: 1433000 MR: - FA: 1,433,000 FAN: 1433000	D: 2025-11-06 FD: 2025-11-06	2 investors
6	RT: Non-brokered Private Placement T: - FT: Non-brokered Private Placement	A: 527500 MR: - FA: $527,500 FAN: 527500	D: 2025-10-03 FD: 2025-10-03	-

Convertible Loan Notes Latest

2026-04-15

$2.7M

Convertible Debt 2026-03-16

$2.7M

Convertible Debt 2026-02-27

$2.7M

View 5 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

John Gevisser

Chief Executive Officer

M

Meghan Geary

Chief Operations Officer

M

Mike Druhan

President, Dermatological Services

H

Heinrich De Lange

Chief Technology Officer

W

Wayne Cockburn

Executive Vice President, Laser

P

Paul Matts

View 17 more team members with Pro

Unlock Full Team Directory

Recent News

MedX Health Corp. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

About MedX Health Corp.

Products & Services

Specialties

Funding History

Growth Metrics

Team & Leadership

Recent News

MedX Health Corp. Announces New Product Launch

Leadership Team Expands with Industry Veteran

Company Recognized as Industry Leader

Key Competitors

Competitor Alpha

Competitor Beta

Competitor Gamma

Competitor Delta

Company Details

Technology Stack